Cargando…

Germline Whole-Gene Deletion of FH Diagnosed from Tumor Profiling

Hereditary leiomyomatosis and renal cell carcinoma (HL (RCC)) entails cutaneous and uterine leiomyomatosis with aggressive type 2 papillary RCC-like histology. HLRCC is caused by pathogenic variants in the FH gene, which encodes fumarate hydratase (FH). Here, we describe an episode of young-onset RC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ueki, Arisa, Sugano, Kokichi, Misu, Kumiko, Aimono, Eriko, Nakamura, Kohei, Tanishima, Shigeki, Tanaka, Nobuyuki, Mikami, Shuji, Hirasawa, Akira, Ando, Miho, Yoshida, Teruhiko, Oya, Mototsugu, Nishihara, Hiroshi, Kosaki, Kenjiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347438/ https://www.ncbi.nlm.nih.gov/pubmed/34360727 http://dx.doi.org/10.3390/ijms22157962

Ejemplares similares

A first Japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline BRCA2 mutation
por: Kosaka, Takeo, et al.
Publicado: (2019)

Germline multigene panel testing revealed a BRCA2 pathogenic variant in a patient with suspected Lynch syndrome
por: Yoshihama, Tomoko, et al.
Publicado: (2020)

TP53 variants in p53 signatures and the clonality of STICs in RRSO samples
por: Akahane, Tomoko, et al.
Publicado: (2022)

Prominent response to platinum‐based chemotherapy in a patient with BRCA2 mutant‐neuroendocrine prostate cancer and MDM2 amplification
por: Daimon, Tatsuaki, et al.
Publicado: (2021)

First successful case of platinum‐based chemotherapy for neuroendocrine prostate cancer with BRCA2 and PTEN alterations
por: Omura, Minami, et al.
Publicado: (2021)

CDK12 and HER2 coamplification in two urothelial carcinomas with rapid and aggressive clinical progression
por: Yanai, Yoshinori, et al.
Publicado: (2020)

Characterization of the STK11 splicing variant as a normal splicing isomer in a patient with Peutz–Jeghers syndrome harboring genomic deletion of the STK11 gene
por: Masuda, Kenta, et al.
Publicado: (2016)

Aggressive prostate cancer with somatic loss of the homologous recombination repair gene FANCA: a case report
por: Hongo, Hiroshi, et al.
Publicado: (2020)

Genetic profiling of patients with adenoid cystic carcinoma of the Bartholin’s glands reveals potential new routes for targeted therapies: a case report
por: Nakamura, Kohei, et al.
Publicado: (2020)

Clinical predominance of whole‐exome sequencing to evaluate microsatellite instability status
por: Takamatsu, Reika, et al.
Publicado: (2023)

Genetic Profiling of Malignant Melanoma Arising from an Ovarian Mature Cystic Teratoma: A Case Report
por: Nakamura, Kohei, et al.
Publicado: (2021)

Germline BRCA2 mutation in a case of aggressive prostate cancer accompanied by spinal bulbar muscular atrophy
por: Hongo, Hiroshi, et al.
Publicado: (2021)

A novel pathogenic variant of the FH gene in a family with hereditary leiomyomatosis and renal cell carcinoma
por: Yagi, Yasuto, et al.
Publicado: (2022)

Germline PMS2 mutation screened by mismatch repair protein immunohistochemistry of colorectal cancer in Japan
por: Sugano, Kokichi, et al.
Publicado: (2016)

Olaparib Monotherapy for BRIP1-Mutated High-Grade Serous Endometrial Cancer
por: Nakamura, Kohei, et al.
Publicado: (2020)

Intratumoral Genomic Heterogeneity May Hinder Precision Medicine Strategies in Patients with Serous Ovarian Carcinoma
por: Nakamura, Kohei, et al.
Publicado: (2020)

Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer
por: Masuda, Tsukasa, et al.
Publicado: (2022)

Squamous cell carcinoma of the prostate with SMARCA4 alteration in a Japanese patient
por: Kaneko, Yuta, et al.
Publicado: (2022)

The first Japanese case of intraductal cancer of the prostate with checkpoint kinase 2 mutation
por: Hongo, Hiroshi, et al.
Publicado: (2022)

Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors
por: Shimozaki, Keitaro, et al.
Publicado: (2021)

Familial pancreatic cancer with PALB2 and NBN pathogenic variants: a case report
por: Abe, Kodai, et al.
Publicado: (2021)

A Japanese patient with ductal carcinoma of the prostate carrying an adenomatosis polyposis coli gene mutation: a case report
por: Umeda, Kota, et al.
Publicado: (2020)

A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations
por: Kobayashi, Hiroaki, et al.
Publicado: (2021)

Castration-resistant prostate cancer patient presenting with whole genome doubling with CDK-12 mutation
por: Baba, Yuto, et al.
Publicado: (2022)

First case of ductal adenocarcinoma of the prostate with MAP3K1 homozygous deletion
por: Shojo, Kazunori, et al.
Publicado: (2021)

A Japanese case of castration-resistant prostate cancer with BRCA2 and RB1 co-loss and TP53 mutation: a case report
por: Iwasawa, Tomohiro, et al.
Publicado: (2022)

Association between germline pathogenic variants in cancer‐predisposing genes and lymphoma risk
por: Usui, Yoshiaki, et al.
Publicado: (2022)

Molecular Features and Clinical Management of Hereditary Gynecological Cancers
por: Ueki, Arisa, et al.
Publicado: (2020)

Pulmonary metastasis secondary to abiraterone‐resistant prostate cancer with homozygous deletions of BRCA2: First Japanese case
por: Izawa, Mizuki, et al.
Publicado: (2020)

Clinical implications of next‐generation sequencing‐based panel tests for malignant ovarian tumors
por: Saotome, Keiko, et al.
Publicado: (2020)

Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls
por: Momozawa, Yukihide, et al.
Publicado: (2019)

Expression level of dihydropyrimidine dehydrogenase is associated with clinical outcome in patients with T1G3 bladder cancer treated with Bacillus Calmette-Guerin
por: Ide, Hiroki, et al.
Publicado: (2014)

Lymphovascular invasion status at transurethral resection of bladder tumors may predict subsequent poor response of T1 tumors to bacillus Calmette-Guérin
por: Fukumoto, Keishiro, et al.
Publicado: (2016)

Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
por: Nakamura, Kohei, et al.
Publicado: (2021)

A Case of Renal Cell Carcinoma and Pheochromocytoma Due to Germline Inactivating Mutation in Fumarate Hydratase (FH)
por: Reda, Sarah Alicia, et al.
Publicado: (2021)

Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes
por: Mizukami, Keijiro, et al.
Publicado: (2020)

Myxofibrosarcoma harboring an MLH1 pathogenic germline variant associated with Muir-Torre syndrome: a case report
por: Nakagawa, Makoto, et al.
Publicado: (2021)

Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy
por: Takamatsu, Kimiharu, et al.
Publicado: (2021)

FH through the retrospectoscope
por: Thompson, Gilbert R.
Publicado: (2021)

Familial Hypercholesterolemia (FH) in Iran: Findings from the Four-Year FH Registry
por: Vaseghi, Golnaz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vr0vr9tqslmdnlr6k6gte6hje1